Why Do Research?

Advances in medicine come from new ideas and approaches developed through research. New treatments must prove to be safe and effective before they can be made available. Researchers learn best through studies called clinical trials. The Center for Women’s Research, located in the Professional Building of Rush University Medical Center, Suite #739, conducts studies of new treatments and medications for medical problems that affect women.

Potential study participants undergo screening procedures to determine their eligibility to enter a study. These screen visits generally include the taking of a medical history, a physical examination, and fasting blood work. Depending on the nature of the study, some screen visits may also include pap smears, mammograms or bone density scans. All study procedures and medications are provided free of charge to the participants. Parking or transportation expenses are also paid.

Current Studies

Benefits of Participation

Volunteering for clinical drug trials provides more benefits than the potential relief of symptoms associated with an illness or condition. Many women gain satisfaction in knowing that they contribute to advancing treatments available for conditions that affect themselves and other women. Additionally, they receive thorough follow-up care and laboratory tests that they may not otherwise be able to afford. Please review the list of currently enrolling studies below. If you or someone you know is interested in any of these studies, please call the Center for Women’s Research at 312-563-2611 to set up a screening appointment. Remember, all participation is voluntary and confidential.

Abbott Laboratories Endometriosis Study

The objective of this study is to evaluate the effectiveness of a daily oral pill compared to placebo pill in the treatment of moderate to severe pain associated with Endometriosis. Women must be between the ages of 18 to 49 and suffer with moderate to severe pain caused by Endometriosis. To qualify women must be clinically diagnosed with Endometriosis in the past 7 years. The duration of this study is approximately 12-18 months and will include 14 visits to the study center.

Abbott Laboratories Study Uterine Fibroids and Heavy Bleeding

This objective of the study is to evaluate the effectiveness of an oral pill for the treatment of uterine fibroids with heavy menstrual bleeding. Women must be between 18-49 years of age, pre-menopausal, and diagnosed with uterine fibroids. The duration of this study is approximately 12 months.

Pharmacosmos Iron Deficiency Anemia Study

The objective of the study is to evaluate the effectiveness of an IV medication in patients suffering from anemia caused by heavy vaginal bleeding. Women must be 18 years or older, have a diagnosis of Anemia with a hemoglobin level less that 11. The duration of this study is approximately 5 to 7 weeks.

Contact our Research Coordinator at 312-563-2611 for more information.

Center for Women’s Research Locations:

12400 S. Harlem Ave. Suite 110, Palos Heights, Illinois 60463

Rush University Medical Center
1725 West Harrison Street
Suite 739
Chicago, IL 60612